Daniel Castellano
@cdanicas
Medical Oncologist. Hospital Univ. 12 de Octubre. Madrid. UCM. Head GU Unit. Executive Member @GUARDconsortitum
ID:1125754626
27-01-2013 18:02:48
6,2K Tweets
3,1K Followers
1,5K Following
Follow People
Toni Choueiri, MD
Senior Executive & Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; 2021 Giants of Cancer Award ⚽ lover; 🚲@PanMass, seen on @msnbc @cnn @TODAYshow @GMA
Enrique Grande
Jefe del Servicio de #Oncología Médica y Director de Investigación Clínica de la Fundación MD Anderson Cancer Center Madrid. Opinions are my own
Petros Grivas
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine
Sumanta K. Pal, MD, FASCO
@cityofhope & @cityofhopeoc prof w focus on #kidneycancer. Want to contribute to my work? E-mail [email protected].
Tom Powles
Interested in Urology Cancers, biomarkers and drug development.
April is #TesticularCancerAwarenessMonth
🍒Early detection is crucial!
🍒Even though it’s highly treatable, awareness remains low, and many cases go unnoticed.
🍒Let’s shift the statistics: Check yourself, discuss openly, and challenge the stigma.
🍒Your health is important!…
😎😎 in the Testicular Cancer Awareness Month! OncoAlert UroTarget Dra. María Natalia Gandur Quiroga Yüksel Ürün
@APCC_Lugano 2024 is coming soon!!
Congrats to #latam KOLs Juan Pablo Sade Maite Bourlon Daniel Castellano for being part of panel members!!
I am proud to announce that I have been named an Advocacy Champion at the #ASCOAdvocacy Summit ! This past year I engaged with my local representatives to improve care for patients w #cancer . #ASCOAdvocacy
#OpenAccess in Nature Medicine
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning
nature.com/articles/s4159…
Fantastic study that uses tens of thousands of cytology cases for training & test sets for assessing CUP patients.
CÁNCER TESTICULAR
📢¡Nuevo episodio de nuestro podcast!
Entrevistamos a:
🔵Daniel Castellano (Daniel Castellano) - Oncólogo médico
🔵Jandro Ybarra - Experiencia personal
Encuentra SUMANDO EN SALUD EN LA RADIO en YouTube y en todas las plataformas de podcast
youtu.be/ocPcXxP2XDs
ctDNA🧬and #BladderCancer : Current Understanding and Beyond w/ Expert Commentary by OncoAlert 🚨faculty Tom Powles 🇬🇧 & James Catto 🇬🇧
Link: go.sn.pub/ctDNA-Bladder-…
Out by our Collaborators at @springer_med
Pinging OncoAlert GU Faculty:
Cristiane D Bergerot Petros Grivas…
APRIL IS TESTICULAR CANCER AWARENESS MONTH. So many great messages out there from all the #TCN members. It's On The Ball The Robin Cancer Trust Baggy Trousers UK Cahonas Scotland UCARE 💙 #DoYouCUs It's in the Bag 🧡🩲🧡 National Germ Cell Group 💙 Orchid Get behind these charities to spread the word! #tcam #tyacam
BIG day. First STAMPEDE2 Site Initiation Visit at The Royal Marsden NHS Foundation Trust in partnership with The ICR stampede2trial.org MRC Clinical Trials Unit at UCL Long time to set up in current environment but hopefully well worth it. AttardLab
#Cobertura #CLOC #ScienceLink
Dr. Daniel Castellano (Daniel Castellano)
Organizado por CLOC: Curso Latinoamericano de Oncología Clínica (@cloc_oncologia)
shorturl.at/prA06
New guidelines alert🚨
The 2024 EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines for #ProstateCancer offer personalized recommendations for screening, diagnosis, and treatment based on the latest data.
Emphasizing risk-adapted approaches and advanced imaging, these guidelines reflect…
ENZA-p trial The Lancet Oncology
authors.elsevier.com/a/1iw3e5EIIgPd…
Enzalutamide + adaptive-dosed (2 or 4) 177 Lu-PSMA617 vs enza alone in mCRPC.
Biomarker guided combination therapy works!
Better response depth/duration with no added tox. ANZUP NHMRC CTC Movember Australia St Vincent's Sydney
Just in 👉data from SWOG Cancer Research Network 1216 trial in mHSPC#prostatecancer👉 PSA level at 3 and 7 months after starting ADT Rx are strongly prognostic of OS: It’s time to design de- or escalation trials based on response biomarkers. OPEN access👉 tinyurl.com/3azhpt4r OncoAlert UroToday.com
